Editas Medicine (EDIT) Accumulated Expenses (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Accumulated Expenses data on file, last reported at $32.6 million in Q4 2025.

• On a quarterly basis, Accumulated Expenses fell 28.89% year-over-year to $32.6 million in Q4 2025; TTM through Dec 2025 was $32.6 million, a 28.89% decrease from a year earlier, with the FY2025 full-year figure at $32.6 million, down 28.89% from the prior year.
• Accumulated Expenses for Q4 2025 stood at $32.6 million, down from $47.5 million in the prior quarter.
• Over the last five years, Accumulated Expenses for EDIT reached as high as $48.1 million in Q2 2025 and fell as low as $5.5 million in Q2 2021.
• Historically, Accumulated Expenses has averaged $26.7 million across 5 years, with a median of $29.5 million in 2023.
• On a YoY basis, Accumulated Expenses climbed as much as 465.49% in 2023 and fell as far as 68.11% in 2023.
• Year by year, Accumulated Expenses stood at $10.2 million in 2021, then surged by 208.06% to $31.3 million in 2022, then rose by 10.44% to $34.6 million in 2023, then jumped by 32.68% to $45.9 million in 2024, then retreated by 28.89% to $32.6 million in 2025.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $32.6 million in Q4 2025, $47.5 million in Q3 2025, and $48.1 million in Q2 2025.